Here are the latest quarterly results of the stocks in the . For more detailed updates, check the latest stock quotes.
Click on title to sort | Jun 2019 | Jun 2020 | YoY %-Change | Get More Info | ||||
---|---|---|---|---|---|---|---|---|
Name | Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (%) |
PAT (%) |
P/E* (x) |
|
AUROBINDO PHARMA | 54,446 | 6,310 | 59,248 | 7,952 | 8.8% | 26.0% | 15.3 | More Info
|
AUROBINDO PHARMA | 54,446 | 6,310 | 59,248 | 7,952 | 8.8% | 26.0% | 15.3 | More Info
|
AUROBINDO PHARMA | 54,446 | 6,310 | 59,248 | 7,952 | 8.8% | 26.0% | 15.3 | More Info
|
AUROBINDO PHARMA | 54,446 | 6,310 | 59,248 | 7,952 | 8.8% | 26.0% | 15.3 | More Info
|
BIOCON | 14,659 | 2,356 | 16,938 | 1,714 | 15.5% | -27.2% | 29.4 | More Info
|
BIOCON | 14,659 | 2,356 | 16,938 | 1,714 | 15.5% | -27.2% | 29.4 | More Info
|
CIPLA | 39,890 | 4,706 | 43,462 | 5,714 | 9.0% | 21.4% | 15.2 | More Info
|
CIPLA | 39,890 | 4,706 | 43,462 | 5,714 | 9.0% | 21.4% | 15.2 | More Info
|
CIPLA | 39,890 | 4,706 | 43,462 | 5,714 | 9.0% | 21.4% | 15.2 | More Info
|
DIVIS LABORATORIES | 11,629 | 2,724 | 17,305 | 4,921 | 48.8% | 80.6% | 53.8 | More Info
|
DIVIS LABORATORIES | 11,629 | 2,724 | 17,305 | 4,921 | 48.8% | 80.6% | 53.8 | More Info
|
GLENMARK PHARMA | 23,229 | 1,093 | 23,448 | 2,540 | 0.9% | 132.5% | N.A. | More Info
|
LUPIN | 44,184 | 3,017 | 35,279 | 1,081 | -20.2% | -64.2% | 18.4 | More Info
|
LUPIN | 44,184 | 3,017 | 35,279 | 1,081 | -20.2% | -64.2% | 18.4 | More Info
|
LUPIN | 44,184 | 3,017 | 35,279 | 1,081 | -20.2% | -64.2% | 18.4 | More Info
|
PIRAMAL ENTERPRISES | 35,063 | 3,771 | 29,373 | 4,606 | -16.2% | 22.1% | N.A. | More Info
|
SUN PHARMA | 83,744 | 15,014 | 75,853 | -24,298 | -9.4% | -261.8% | 13.0 | More Info
|
SUN PHARMA | 83,744 | 15,014 | 75,853 | -24,298 | -9.4% | -261.8% | 13.0 | More Info
|
ZYDUS LIFESCIENCES | 34,963 | 3,148 | 35,146 | 4,543 | 0.5% | 44.3% | 11.4 | More Info
|
ZYDUS LIFESCIENCES | 34,963 | 3,148 | 35,146 | 4,543 | 0.5% | 44.3% | 11.4 | More Info
|
Sector Aggregate | 818,286 | 99,759 | 816,515 | 33,099 | -0.2% | -66.8% | ||
* Trailing 12 months earnings, excluding extraordinary / exceptional items. |
Mar 2020 Results | Sep 2020 Results | Latest Quarter Results | View All Results |